You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

KRAS G12C

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression = 1% and an STK11

Recruiting
  • Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation
  • Montpellier, France
  • +7 more
Dec 19, 2022

Solid Tumor, Adult, EphA2 Overexpression, KRAS G12V Trial in Beijing (KRAS-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting
  • Solid Tumor, Adult
  • +4 more
  • KRAS-EphA-2-CAR-DC
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022

Advanced NSCLC Trial in Jilin (pemetrexed, Cetuximab, cis-platinum)

Not yet recruiting
  • Advanced Non-Small Cell Lung Cancer
  • Jilin, Changchun, China
    Jilin Province Cancer Hospital
Aug 15, 2022

NSCLC Trial in Charleston (Sotorasib and Tarloxotinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Sotorasib and Tarloxotinib
  • Charleston, South Carolina
    Hollings Cancer Center at Medical University of South Carolina
Mar 28, 2022

Non Small Cell Lung Cancer Trial in Seoul (sotorasib)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jul 5, 2022

Non Small Cell Lung Cancer Trial in Nashville (AMG 510, MVASI)

Recruiting
  • Non Small Cell Lung Cancer
  • Nashville, Tennessee
    Vanderbilt Ingram Cancer Center
Jun 28, 2022

KRAS P.G12C, Pancreatic Cancer Trial in Beijing (JAB-21822)

Not yet recruiting
  • KRAS P.G12C
  • Pancreatic Cancer
  • Beijing, Beijing, China
  • +1 more
Aug 18, 2023

Advanced Solid Tumor Trial (YL-15293)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Dec 14, 2021

Advanced Solid Tumor Trial in Houston, San Antonio (MRTX849, Palbociclib)

Recruiting
  • Advanced Solid Tumor
  • Houston, Texas
  • +1 more
Feb 18, 2022

Advanced Cancer, Metastatic Cancer, Malignant Tumor Trial in Santa Rosa (adagrasib (MRTX849))

Available
  • Advanced Cancer
  • +2 more
  • adagrasib (MRTX849)
  • Santa Rosa, California
    Providence Medical Group Santa Rosa - Cancer Center
Jan 19, 2022

Advanced Solid Tumor, NSCLC, CRC Trial in United States (JAB-21822 (KRAS G12C inhibitor), Cetuximab (EGFR inhibitor))

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • JAB-21822 (KRAS G12C inhibitor)
  • Cetuximab (EGFR inhibitor)
  • Phoenix, Arizona
  • +3 more
Sep 7, 2021

Non Small Cell Lung Cancer, KRAS Activating Mutation Trial in United States (VS-6766 and sotorasib)

Recruiting
  • Non Small Cell Lung Cancer
  • KRAS Activating Mutation
  • avutometinib (VS-6766) and sotorasib
  • Washington, District of Columbia
  • +6 more
Jan 31, 2023

Advanced Solid Tumors Trial in Worldwide (BMS-986466, Adagrasib, Cetuximab)

Not yet recruiting
  • Advanced Solid Tumors
  • Birmingham, Alabama
  • +24 more
Aug 29, 2023

Advanced Cancer, Metastatic Cancer, Malignant Tumor of Colon Trial in United States (MRTX849, BI 1701963)

Active, not recruiting
  • Advanced Cancer
  • +4 more
  • Saint Louis, Missouri
  • +3 more
Apr 4, 2022

Colo-rectal Cancer Trial in Manchester (therascreen® KRAS RGQ PCR Kit)

Recruiting
  • Colo-rectal Cancer
  • therascreen® KRAS RGQ PCR Kit
  • Manchester, United Kingdom
    QIAGEN Gaithersburg, Inc
Apr 20, 2022

Advanced Solid Tumor Trial in Shanghai (SY-5933)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, China
    Shanghai Pulmonary Hospital
Aug 16, 2023

Advanced Solid Tumor Trial in Whittier, New York, Houston (YL-15293)

Recruiting
  • Advanced Solid Tumor
  • Whittier, California
  • +2 more
Nov 11, 2021

NSCLC Trial in Shanghai, Hangzhou (D-1553, Other)

Not yet recruiting
  • NSCLC
  • Shanghai, Shanghai, China
  • +1 more
Aug 11, 2022

Advanced Colorectal Cancer, Small Intestinal Cancer, Appendiceal Cancer Trial in China (JAB-21822, Cetuximab)

Recruiting
  • Advanced Colorectal Cancer
  • +2 more
  • Beijing, Beijing, China
  • +11 more
Mar 22, 2022

KRAS P.G12C, Non Small Cell Lung Cancer Trial in France (Sotorasib 120Mg Tab)

Recruiting
  • KRAS P.G12C
  • Non Small Cell Lung Cancer
  • Sotorasib 120Mg Tab
  • Lyon, France
  • +3 more
Dec 16, 2022

Slow-Flow Vascular Malformation, Fast-Flow Vascular Malformation, Vascular Malformations Trial in Parkville (Alpelisib,

Not yet recruiting
  • Slow-Flow Vascular Malformation
  • +17 more
  • Parkville, Victoria, Australia
    The Royal Children's Hospital
Aug 7, 2023

Advanced Solid Tumors Trial in Chengdu (GEC255 tablets)

Recruiting
  • Advanced Solid Tumors
  • GEC255 tablets
  • Chengdu, Sichuan, China
    China West Hospital
Mar 14, 2023

Advanced Solid Tumor, NSCLC, Colorectal Cancer Trial in Australia, United States (LY3499446, Abemaciclib, Cetuximab)

Terminated
Has Results
  • Advanced Solid Tumor
  • +2 more
  • Indianapolis, Indiana
  • +5 more
Oct 27, 2021

Metastatic Non Small Cell Lung Cancer, KRAS G12C Trial in Worldwide (Sotorasib, Lenvatinib)

Not yet recruiting
  • Metastatic Non Small Cell Lung Cancer
  • KRAS G12C
  • Innsbruck, Austria
  • +14 more
Sep 28, 2023

KRAS G12C Mutant Solid Tumors, NSCLC, Carcinoma, Colorectal Trial in Worldwide (JDQ443, TNO155, tislelizumab)

Recruiting
  • KRAS G12C Mutant Solid Tumors
  • +9 more
  • Atlanta, Georgia
  • +31 more
Jul 7, 2022